US81727U1051 - Common Stock
GERMANTOWN, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...
Curious about the stocks that are showing activity after the closing bell on Friday?
$16 million upfront with the potential for an additional $16 million upon the exercise in full of warrants...
Event featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management...
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes...
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the...
GERMANTOWN, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...
SENS stock results show that Senseonics Holdings met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
SENS stock results show that Senseonics Holdings met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Senseonics Holdings (SENS) stock fell 9% despite a Q4 beat as analysts pointed to concerns over demand for its Eversense glucose monitoring device. Read more here.
Senseonics beats expectations with Q4 earnings as GAAP EPS comes in at -$0.03, surpassing estimates by $0.01.
Major earnings expected after the bell on Thursday include:Zscaler (ZS)Hewlett Packard Enterprise Company (HPE)Dell Technologies (DELL)Autodesk (ADSK)Veeva...
/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company...
Make sure you have your sights set on these penny stocks to watch. Each has a strong upside and positive growth prospects for the future.
Senseonics Holdings expects to report revenues of $8 million for Q4 2023 and $22 million for full year 2023, with cash balance of $109.8 million.